Early diagnosis and treatment of thrombocytopenia and hypofibrinogenemia in cardiac surgery by novel viscoelastic testing devise,Quantra-Qplus system
Not Applicable
Recruiting
- Conditions
- Patients undergoing caridiovascular surgery with cardiopulmonary bypass
- Registration Number
- JPRN-jRCT1032220207
- Lead Sponsor
- Takano Hiroshi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
1)Patients with written informed consent
2)Caridiovascular surgery patients using cardiopulmonary bypass
3)Patients over 18 years of age at the time of concent
Exclusion Criteria
1)Patients undergoing emergency surgery
2)Patients who may be pregnant
3)Heart transplant surgery.
4)Cardiac surgey reoperation .
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Estimation of cut-off values for FCS(fibrinogen clot stiffness) and PCS(platelet clot stiffness)measured by Quantra Qplus system to predict a blood fibrinogen concentration of less than 150mg/dl and a blood platelet count of less than 70000/mm3
- Secondary Outcome Measures
Name Time Method Correlation of blood fibrinogen levels with Quantra-Qplus system measurements of FCS.<br>Correlation of blood platelet counts with Quantra-Qplus system measurements of PCS .